Supportive and Palliative Care, Royal Surrey County Hospital NHS Foundation Trust, Guildford, Surrey, UK
Supportive and Palliative Care, Royal Surrey County Hospital NHS Foundation Trust, Guildford, Surrey, UK.
BMJ Support Palliat Care. 2020 Jun;10(2):242-247. doi: 10.1136/bmjspcare-2019-002127. Epub 2020 Jan 29.
The estimated prevalence of alcohol use disorders in patients with advanced cancer is reported as 4%-38%. There are limited data regarding alcohol and drug use disorders in caregivers of patients with cancer and the effects on other issues.
To establish the prevalence of alcohol and drug use disorders in a large cohort of patients with advanced cancer and their caregivers.To evaluate the relationship between alcohol and drug use disorders and patient symptoms and caregiver burden.
The patient with cancer and caregiver completed the Alcohol Use Disorders Identification Tool, CAGE questionnaire and Drug Abuse Screening Test. The patient completed the Memorial Symptom Assessment Scale-Short Form, and the caregiver completed the Zarit Burden Questionnaire.Statistical analysis compared cases and non-cases of alcohol and drug use disorders with symptom and burden score.
SETTING/PARTICIPANTS: Patients with cancer, and their caregivers, were recruited from 11 UK sites, 6 hospices and 5 hospitals.
Five hundred and seven patients and their caregivers were recruited. Twenty-seven patients (5%) and 44 caregivers (9%) screened positively for alcohol use disorders on the Alcohol Use Disorders Identification Tool. Thirty patients (6%), and 16 caregivers (3%), screened positively for drug abuse problems on the Drug Abuse Screening Test.There was a significantly higher carer burden score in caregivers screening positively for alcohol and drug abuse problems.
The prevalence of alcohol use disorders in patients with cancer and caregivers was lower than reported in previous studies. Caregiver burden scores were significantly higher in carers screening positively for alcohol and drug use disorders.
Trial registered National Institute for Health Research Clinical Research Network Portfolio (CPMS ID 30723) IRAS ID 198753.
据报道,晚期癌症患者的酒精使用障碍患病率为 4%-38%。关于癌症患者的照顾者的酒精和药物使用障碍以及对其他问题的影响,数据有限。
在一个大型晚期癌症患者及其照顾者队列中确定酒精和药物使用障碍的患病率。评估酒精和药物使用障碍与患者症状和照顾者负担之间的关系。
癌症患者和照顾者完成了酒精使用障碍识别工具、CAGE 问卷和药物滥用筛查测试。患者完成了纪念症状评估量表-短表,照顾者完成了 Zarit 负担问卷。统计分析比较了酒精和药物使用障碍病例与非病例的症状和负担评分。
地点/参与者:从英国的 11 个地点、6 家临终关怀医院和 5 家医院招募癌症患者及其照顾者。
共招募了 507 名患者及其照顾者。27 名患者(5%)和 44 名照顾者(9%)在酒精使用障碍识别工具上筛查出酒精使用障碍阳性。30 名患者(6%)和 16 名照顾者(3%)在药物滥用筛查测试上筛查出药物滥用问题阳性。在筛查出酒精和药物滥用问题阳性的照顾者中,照顾者的负担评分显著更高。
癌症患者及其照顾者的酒精使用障碍患病率低于先前研究报告的患病率。在筛查出酒精和药物使用障碍阳性的照顾者中,照顾者的负担评分显著更高。
英国国家卫生研究院临床研究网络组合(CPMS ID 30723)临床试验注册号;IRAS 标识符 198753。